EO 14398 - pcmid A17 - model development and in vivo screening of antivirals directed against select togaviruses
Active Awarded
- Contract number
- 75N93026F00001
- Awardee
-
Colorado State University UEI LT9CXX8L19G1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $197,555
Award facts
- Opportunity
-
- RTOPA17 Solicitation number
- Contract value 20% obligated
-
- $197,555.00 Current, with exercised options
- $993,995.00 Potential, with all options
- Completion date 39% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Fort Collins, CO 80521, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Colorado State University on June 2, 2026, under the Preclinical Models of Infectious Diseases indefinite delivery contract for model development and in vivo screening of antivirals directed against select togaviruses, with a ceiling value of $993,995.
The Preclinical Models of Infectious Diseases IDV, valued at $146.3 million with an ordering period through July 14, 2031, supports NIAID's mission to understand, treat, and prevent infectious diseases with pandemic potential and antimicrobial resistant infections. The order encompasses work across three task areas: small animal models, non-human primate models, and animal replacement and non-traditional animal models of infectious diseases. Place of performance is Fort Collins, Colorado. The order is priced on a cost no-fee basis with an ultimate completion date of June 1, 2027. No set-aside was used. Colorado State University may subcontract with specialized partners to expand research capacity under the parent vehicle.
Quick answers
Who was awarded contract 75N93026F00001?
75N93026F00001 was awarded to Colorado State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 2, 2026.
How much is contract 75N93026F00001 worth?
The government has obligated $197,555 on 75N93026F00001. Its potential value, with all options, is $993,995.
Is contract 75N93026F00001 an order under another contract?
Yes. 75N93026F00001 is a delivery order under 75N93024D00009, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93026F00001 competed?
The extent of competition for 75N93026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award